Christiana Blair

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman, David Chien Lye, David S.C. Hui et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner et al. · JAMA · 2020 · 1.3K citations · Full text

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

Nazzareno Galiè, Joan Albert Barberà, Adaani Frost et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial

Gerry Coghlan, Nazzareno Galiè, Joan Albert Barberà et al. · Annals of the Rheumatic Diseases · 2016 · 174 citations · Full text

Patients with pulmonary arterial hypertension with and without cardiovascular risk factors: Results from the AMBITION trial

Vallerie V. McLaughlin, Jean‐Luc Vachiéry, Ronald J. Oudiz et al. · The Journal of Heart and Lung Transplantation · 2019 · 116 citations · Full text